What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Evangelos S. Gragoudas spends much of his time researching Surgery, Ophthalmology, Eye disease, Choroid and Visual acuity.
His Surgery study combines topics in areas such as Retinal pigment epithelium, Retina, Relative risk and Risk factor.
The Ophthalmology study combines topics in areas such as Retinopathy and Neovascularization.
His study in Eye disease is interdisciplinary in nature, drawing from both Melanoma, Maculopathy, Radiation therapy and Nuclear medicine.
His research investigates the connection between Choroid and topics such as Optic nerve that intersect with issues in Cumulative dose.
His Visual acuity research integrates issues from Average duration, Retinal detachment and Randomized controlled trial.
His most cited work include:
- Pegaptanib for Neovascular Age-Related Macular Degeneration (1865 citations)
- Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration (1100 citations)
- Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. (808 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Ophthalmology, Melanoma, Pathology, Surgery and Eye disease.
In his research, Fundus and Photosensitizer is intimately related to Choroid, which falls under the overarching field of Ophthalmology.
His studies in Melanoma integrate themes in fields like Ciliary body, Internal medicine, Radiation therapy, Metastasis and Enucleation.
Evangelos S. Gragoudas does research in Surgery, focusing on Survival rate specifically.
The various areas that Evangelos S. Gragoudas examines in his Eye disease study include Retinopathy and Retinal detachment.
Evangelos S. Gragoudas focuses mostly in the field of Fluorescein angiography, narrowing it down to topics relating to Verteporfin and, in certain cases, Cancer research.
He most often published in these fields:
- Ophthalmology (28.08%)
- Melanoma (27.34%)
- Pathology (23.15%)
What were the highlights of his more recent work (between 2011-2021)?
- Melanoma (27.34%)
- Ophthalmology (28.08%)
- Cancer research (6.90%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Melanoma, Ophthalmology, Cancer research, Pathology and Visual acuity.
Evangelos S. Gragoudas combines subjects such as Radiation therapy and Metastasis with his study of Melanoma.
His Radiation therapy study is concerned with the larger field of Surgery.
His work deals with themes such as Beam and Ranibizumab, which intersect with Ophthalmology.
Evangelos S. Gragoudas has included themes like Antagonist and Bioinformatics in his Pathology study.
His Visual acuity research incorporates themes from Choroid, Clinical trial, Statistical significance and Macular degeneration.
Between 2011 and 2021, his most popular works were:
- Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. (184 citations)
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation (123 citations)
- Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment. (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary areas of study are Cancer research, Melanoma, Cell growth, PI3K/AKT/mTOR pathway and Internal medicine.
Evangelos S. Gragoudas focuses mostly in the field of Melanoma, narrowing it down to matters related to Germline mutation and, in some cases, Mutant and Wild type.
His study looks at the relationship between Cell growth and topics such as Verteporfin, which overlap with CTGF, Cell, Hippo signaling pathway and HEK 293 cells.
His research investigates the link between Metastasis and topics such as Radiation therapy that cross with problems in Visual acuity.
His research integrates issues of Germline, Pathology, Eye neoplasm, Cutaneous melanoma and Ocular Melanoma in his study of BAP1.
In Angiogenesis, Evangelos S. Gragoudas works on issues like Immunology, which are connected to Macular degeneration.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
